250 related articles for article (PubMed ID: 19898969)
1. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
Coyne C; Nikiforov YE
Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
[TBL] [Abstract][Full Text] [Related]
2. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
[TBL] [Abstract][Full Text] [Related]
3. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
[TBL] [Abstract][Full Text] [Related]
4. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
Boutross-Tadross O; Saleh R; Asa SL
Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
[TBL] [Abstract][Full Text] [Related]
5. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
6. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
[TBL] [Abstract][Full Text] [Related]
7. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
[TBL] [Abstract][Full Text] [Related]
8. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
9. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract][Full Text] [Related]
10. Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature.
Siegel MR; Wolsky RJ; Alvarez EA; Mengesha BM
Arch Gynecol Obstet; 2019 Dec; 300(6):1693-1707. PubMed ID: 31679038
[TBL] [Abstract][Full Text] [Related]
11. Synchronous Independent Papillary Thyroid Carcinomas in Struma Ovarii and the Thyroid Gland With Different
Gomes-Lima CJ; Nikiforov YE; Lee W; Burman KD
J Endocr Soc; 2018 Aug; 2(8):944-948. PubMed ID: 30087949
[TBL] [Abstract][Full Text] [Related]
12. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
[TBL] [Abstract][Full Text] [Related]
13. Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.
Sadow PM; Heinrich MC; Corless CL; Fletcher JA; Nosé V
Endocr Pathol; 2010 Jun; 21(2):73-9. PubMed ID: 20012784
[TBL] [Abstract][Full Text] [Related]
14. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
[TBL] [Abstract][Full Text] [Related]
15. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
Smith LP; Brubaker LW; Wolsky RJ
Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
[TBL] [Abstract][Full Text] [Related]
17. Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies.
Ciccarelli A; Valdes-Socin H; Parma J; Khoo SK; Schoumans J; Colao A; Hamoir E; Beckers A
Eur J Endocrinol; 2004 Apr; 150(4):431-7. PubMed ID: 15080771
[TBL] [Abstract][Full Text] [Related]
18. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
Ma D; Guseva NV; Dahmoush L; Robinson RA
Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816
[TBL] [Abstract][Full Text] [Related]
19. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
McCluggage WG
Histopathology; 2024 Jan; 84(2):288-290. PubMed ID: 38110823
[No Abstract] [Full Text] [Related]
20. Pathology of Struma Ovarii: A Report of 96 Cases.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]